Mckesson Europe AG (CLS1):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Mckesson Europe AG (CLS1) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11502
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥100,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Mckesson Europe AG (Mckesson Europe), formerly known as Celesio AG, is a provider of logistics and services to healthcare and pharmaceutical sectors across Europe. The company is involved in providing distribution solution to its wholesale, institutional and retail customers and delivering pharmaceutical and other healthcare related products to owned, franchise-like and independent pharmacies. McKesson Europe is also one of the leading pharmacy operators in Europe. In addition to these, it provides health advices to customers. The company’s operation is spread across Germany, the UK, France, Austria, Republic of Ireland, Denmark, Italy, Slovenia, and other countries. It operates as a subsidiary of McKesson Corporation. Mckesson Europe is headquartered in Stuttgart, Germany.

Mckesson Europe AG (CLS1) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Mckesson Europe AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mckesson Europe AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Mckesson Europe AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mckesson Europe AG, Medical Devices Deals, 2012 to YTD 2018 8
Mckesson Europe AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Mckesson Europe AG, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Sanova Pharma to Acquire Okopharm, Okomed and BasoVital Products from Okopharm 10
Lloyds Pharmacy to Acquire Pharmacy Business from J Sainsbury for USD194.7 Million 11
Private Equity 12
Penta Investments Receives Regulatory Approval To Acquire Lekarny Lloyds And Gehe Pharma From Celesio For US$104 Million 12
Debt Offering 14
Celesio Completes Private Placement Of Bonds Due 2016 For US$453 Million 14
Acquisition 15
Celesio Acquires Remaining 40% Stake in Oncoprod 15
McKesson Completes Acquisition Of Celesio For US$8.49 Billion 16
Elliott Management Acquires Additional Stake In Celesio 18
Franz Haniel Sells 4.6% Stake In Celesio For US$129.6 Million 19
Zur Rose Acquires DocMorris From Celesio For US$32.4 Million 20
Owens & Minor Completes Acquisition Of Movianto From Celesio For US$158 Million 21
Celesio Completes Acquisition Of Remaining 49.9% Stake In Panpharma For US$341 Million 22
Mckesson Europe AG – Key Competitors 23
Mckesson Europe AG – Key Employees 24
Mckesson Europe AG – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Mckesson Europe AG, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Mckesson Europe AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Mckesson Europe AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mckesson Europe AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Mckesson Europe AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mckesson Europe AG, Medical Devices Deals, 2012 to YTD 2018 8
Mckesson Europe AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Sanova Pharma to Acquire Okopharm, Okomed and BasoVital Products from Okopharm 10
Lloyds Pharmacy to Acquire Pharmacy Business from J Sainsbury for USD194.7 Million 11
Penta Investments Receives Regulatory Approval To Acquire Lekarny Lloyds And Gehe Pharma From Celesio For US$104 Million 12
Celesio Completes Private Placement Of Bonds Due 2016 For US$453 Million 14
Celesio Acquires Remaining 40% Stake in Oncoprod 15
McKesson Completes Acquisition Of Celesio For US$8.49 Billion 16
Elliott Management Acquires Additional Stake In Celesio 18
Franz Haniel Sells 4.6% Stake In Celesio For US$129.6 Million 19
Zur Rose Acquires DocMorris From Celesio For US$32.4 Million 20
Owens & Minor Completes Acquisition Of Movianto From Celesio For US$158 Million 21
Celesio Completes Acquisition Of Remaining 49.9% Stake In Panpharma For US$341 Million 22
Mckesson Europe AG, Key Competitors 23
Mckesson Europe AG, Key Employees 24
Mckesson Europe AG, Subsidiaries 25

List of Figures
Mckesson Europe AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Mckesson Europe AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Mckesson Europe AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Mckesson Europe AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mckesson Europe AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Mckesson Europe AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mckesson Europe AG, Medical Devices Deals, 2012 to YTD 2018 8

★海外企業調査レポート[Mckesson Europe AG (CLS1):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Empresa Electricidad del Peru SA (ELECPBC1):企業の財務・戦略的SWOT分析
    Empresa Electricidad del Peru SA (ELECPBC1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • ComfortDelGro Corporation Limited:企業の戦略・SWOT・財務情報
    ComfortDelGro Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary ComfortDelGro Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Hafslund ASA:企業の戦略的SWOT分析
    Hafslund ASA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Salter Labs-医療機器分野:企業M&A・提携分析
    Summary Salter Labs (Salter) is a medical device company that offers home, HME and acute care products. The company offers products which include swivel connector, whisper and silhouette cannula, visible tubing, petite cannula sensitive grips, static connector and humidifier tubing. It also offers o …
  • Channel Four Telivision Corp:企業の戦略的SWOT分析
    Channel Four Telivision Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • EnWave Corp (ENW):企業の財務・戦略的SWOT分析
    EnWave Corp (ENW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Chicago Bridge & Iron Company N.V.:企業の戦略・SWOT・財務情報
    Chicago Bridge & Iron Company N.V. - Strategy, SWOT and Corporate Finance Report Summary Chicago Bridge & Iron Company N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Modernizing Medicine Inc:医療機器:M&Aディール及び事業提携情報
    Summary Modernizing Medicine Inc (MMI) is a technology company that offers healthcare electronic health records (EHR) solutions. The company offers data management system and electronic medical record systems in the areas of gastroenterology, ophthalmology, orthopedics, otolaryngology, pain manageme …
  • Lake Region Electric Cooperative Inc:企業の戦略的SWOT分析
    Lake Region Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Yes Bank Ltd:企業のM&A・事業提携・投資動向
    Yes Bank Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Yes Bank Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Select Medical Holdings Corporation:企業の戦略・SWOT・財務分析
    Select Medical Holdings Corporation - Strategy, SWOT and Corporate Finance Report Summary Select Medical Holdings Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Nautilus Marine Services Plc (NAUT):石油・ガス:M&Aディール及び事業提携情報
    Summary Nautilus Marine Services Plc (Nautilus Marine Services), formerly Global Energy Development PLC is an oil and gas company that offers petroleum production and oil and gas exploration and development services. The company’s services include production, drilling, and exploration of properties, …
  • San Juan Basin Royalty Trust (SJT):企業の財務・戦略的SWOT分析
    Summary San Juan Basin Royalty Trust (SJT) is a trust that has overriding royalty interest divided out of Southland Royalty's oil and gas leasehold and royalty interest in the San Juan Basin of northwestern New Mexico. The trust’s underlying properties include royalty interests, overriding royalty i …
  • Mitsubishi Heavy Industries, Ltd.:企業の戦略・SWOT・財務分析
    Mitsubishi Heavy Industries, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Heavy Industries, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Barclaycard:企業の戦略・SWOT・財務情報
    Barclaycard - Strategy, SWOT and Corporate Finance Report Summary Barclaycard - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Beijing Beilu Pharmaceutical Co Ltd (300016):製薬・医療:M&Aディール及び事業提携情報
    Summary Beijing Beilu Pharmaceutical Co Ltd (Beijing BeiLu) is a manufacturer of traditional Chinese medicine preparation and psychiatric products. The company provides product portfolio such as contrast media products, anti anxiety medicines and oral antihyperglycemic agents, among others. Its cont …
  • Allergan Plc (AGN)-医療機器分野:企業M&A・提携分析
    Summary Allergan Plc (Allergan) is a specialty pharmaceutical company that develops and sells branded pharmaceuticals, biosimilar and over-the-counter (OTC) pharmaceutical products. It offers products in the areas of eye care, medical aesthetics, dermatology, central nervous system, gastroenterology …
  • Hyundai Heavy Industries Co., Ltd.:企業の戦略・SWOT・財務情報
    Hyundai Heavy Industries Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Hyundai Heavy Industries Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Alfresa Holdings Corporation:企業の戦略・SWOT・財務情報
    Alfresa Holdings Corporation - Strategy, SWOT and Corporate Finance Report Summary Alfresa Holdings Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Noble Life Sciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary Noble Life Sciences Inc (Noble Life Sciences) is a contract research organization that offers drug, vaccine, and medical device development services. The company provides preclinical services such as analytical and laboratory services, disease and animal models, drug pharmacology and explora …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆